March 3, 2008 - Vermillion Inc. has entered into an exclusive license agreement with Stanford University to develop and commercialize a novel biomarker panel used to assess the risk of peripheral artery disease (PAD), as both groups aim to develop tools to expedite treatment and enhance patient outcomes.
Under the terms of the agreement, Vermillion is granted exclusive rights to the biomarker panel, and will undertake the development and commercialization of a PAD blood test, which utilizes the multi-marker panel to stratify an individual’s risk for developing the disease.

March 3, 2008 – The FDA granted 510(k) clearance for the AIGISRX CRMD Anti-Bacterial Envelope by Tyrxpharma, a cardiac rhythm medical device intended to immobilize and reduce bacterial infection of a pacemaker or implantable cardioverter defibrillator (ICD) in order to create a stable environment when implanted in the body.

March 3, 2008 – Covidien said that it has tentative FDA clearance for its Abbreviated New Drug Application (ANDA) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, a generic of Cardiolite1, which is a myocardial perfusion imaging agent used for detecting coronary artery disease.

The branded product is utilized in nearly 60 percent of the 15 million myocardial perfusion imaging studies performed in the U.S. annually.

February 29, 2008 - Physicians began performing the first European implants of the COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and the TELIGEN implantable cardioverter defibrillator (ICD) by Boston Scientific Corp. after both devices received CE Mark last month.

February 29, 2008 – A record-breaking 28,400 people and 900 companies attended the 2008 Annual Healthcare Information and Management Systems Society (HIMSS) Conference and Exhibition in Orlando, FL this week, demonstrating the continuing growth of the Health IT industry.

Previously, HIMSS' most successful conference was in San Diego in 2006, where 24,870 healthcare IT professionals attended and 859 companies exhibited.

McKesson's ECG Management module, a component of Horizon Cardiology, is a fully integrated, Web-enabled, electrocardiography (ECG) waveform data management product, said the company.

Philips' cardiovascular IT solution, the enhanced Xcelera solution is an integrated multimodality solution reportedly provides one access point for all relevant cardiology information, such as cardiovascular ultrasound, CT, MR, nuclear medicine, ECGs and electrophysiology recording signals, as well as long-term storage and enterprise distribution of multimedia studies.

February 28, 2008 - Search giant Google launched Google Health and announced major industry partners on Thursday, aiming to be the Intuit for personal healthcare, where people can access all their health information in one spot.

Google Chief Executive Eric Schmidt answered reporters' questions after announcing Google Health.

February 28, 2008 - The first human received Medtronic’s investigational bifurcation stent, a Y-shaped design that matches the anatomy of lesions that form at the junctions of coronary arteries, intended to reduce the procedural challenges associated with current two-stent bifurcation techniques.

February 28,, 2008 - Following the line of enterprise-wide solutions, Emageon highlighted its enterprise medical information technology systems for hospitals and healthcare networks, which include RadSuite, HeartSuite and a pathology and orthopedic specialty suite.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now